Novartis Pharma GmbH, Salutas Pharma GmbH
PolandAll drugs from this manufacturer
-
The medicine is used in adults to prevent the immune system from rejecting a transplanted kidney, heart, or liver. It is used in combination with other medicines, such as cyclosporine, tacrolimus, or corticosteroids.
Dosage form: tablets
Active substance Dosage everolimus 0.25 mg ATC: L04AA18
-
The medicine is used in adults to prevent the immune system from rejecting a transplanted kidney, heart, or liver.
Dosage form: tablets
Active substance Dosage everolimus 0.5 mg ATC: L04AA18
-
The medicine is used in adults to prevent the immune system from rejecting a transplanted kidney, heart, or liver.
Dosage form: tablets
Active substance Dosage everolimus 0.75 mg ATC: L04AA18
-
The medicine is used in adults to prevent the immune system from rejecting a transplanted kidney, heart, or liver. It is taken together with other medicines, such as cyclosporine, tacrolimus, or corticosteroids.
Dosage form: tablets
Active substance Dosage everolimus 1 mg ATC: L04AA18